Left: Founder Dr Jane Cardosa
Center: Dr Uwe Schlokat
Right: Michelle Gan

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …